Table 5.
Author (year) | Outcome | Measure of effect (precision) | Sociodemographic correlates | Psychosocial correlates | HIV‐related correlates | |||
---|---|---|---|---|---|---|---|---|
Risk indicators | Protective indicators | Risk indicators | Protective indicators | Risk indicators | Protective indicators | |||
Besthorn et al. (2018) [68] | Anxiety symptoms | β (Se) | NR | NR |
NR |
‐Higher social support: −0.16 (0.06) | NR | NR |
Boyes et al. (2018) [69] | Anxiety symptoms | β (Se) | NR |
‐Better overall health: −0.18 (0.08) |
‐Internalized stigma: 0.54 (0.07) ‐Past year emotional abuse: 1.17 (0.19) ‐History of sexual abuse: 1.08 (0.34) ‐Bullying victimisation: 0.15 (0.02) ‐Poor parental monitoring: 0.02 (0.01) ‐Anticipated stigma: 0.30 (0.08) |
‐Self‐efficacy: −0.06 (0.02) ‐Positive parenting: −0.05 (0.01) ‐Access to clinic support group: −0.43 (0.14) |
‐ART side effects: 0.51 (0.17) | NR |
Haas et al., 2020 [78] | Anxiety symptoms | AOR (95% CI) | NR |
‐Younger age: 10 to 12 years age group vs. 16 to 19 years age group = 0.05 (0.01 to 0.37) 13 to 15 years age group vs. 16 to 19 years group = 0.19 (0.06 to 0.56) |
‐History of physical violence: 2.74 (1.09 to 6.85) | NR | NR | NR |
Hoare et al. (2019) [66] | Anxiety symptoms | β (95% CI) | NR | NR | ‐Stressful life events: 0.72 (0.44 to 1.01) | NR | NR | NR |
West et al. (2018) [58] | Anxiety symptoms | APR (95% CI) | NR | NR | NR | ‐Higher social support: 0.30 (0.13 to 0.71) | NR | NR |
APR, Adjusted prevalence ratio; ART, Antiretroviral therapy; CI, Confidence interval; NR, Not reported; Se, Standard error; β, Beta coefficients (adjusted).